Coffee consumption and mortality in three Eastern European countries: results from the HAPIEE (Health, Alcohol and Psychosocial factors In Eastern Europe) study

. 2017 Jan ; 20 (1) : 82-91. [epub] 20160714

Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic

Typ dokumentu časopisecké články, multicentrická studie, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid27411779

Grantová podpora
Wellcome Trust - United Kingdom
R01 AG023522 NIA NIH HHS - United States
064947/Z/01/Z Wellcome Trust - United Kingdom
081081/Z/06/Z Wellcome Trust - United Kingdom

OBJECTIVE: To test the association between coffee consumption and risk of all-cause, CVD and cancer death in a European cohort. DESIGN: Prospective cohort study. Cox proportional hazards models with adjustment for potential confounders to estimate multivariable hazard ratios (HR) and 95 % CI were used. SETTING: Czech Republic, Russia and Poland. SUBJECTS: A total of 28561 individuals followed for 6·1 years. RESULTS: A total of 2121 deaths (43·1 % CVD and 35·7 % cancer mortality) occurred during the follow-up. Consumption of 3-4 cups coffee/d was associated with lower mortality risk in men (HR=0·83; 95 % CI 0·71, 0·99) and women (HR=0·63; 95 % CI 0·47, 0·84), while further intake showed non-significant reduced risk estimates (HR=0·71; 95 % CI 0·49, 1·04 and HR=0·51; 95 % CI 0·24, 1·10 in men and women, respectively). Decreased risk of CVD mortality was also found in men (HR=0·71; 95 % CI 0·54, 0·93) for consumption of 3-4 cups coffee/d. Stratified analysis revealed that consumption of a similar amount of coffee was associated with decreased risk of all-cause (HR=0·61; 95 % CI 0·43, 0·87) and cancer mortality (HR=0·59; 95 % CI 0·35, 0·99) in non-smoking women and decreased risk of all-cause mortality for >4 cups coffee/d in men with no/moderate alcohol intake. CONCLUSIONS: Coffee consumption was associated with decreased risk of mortality. The protective effect was even stronger when stratification by smoking status and alcohol intake was performed.

Zobrazit více v PubMed

Grigg D (2003) The worlds of tea and coffee: patterns of consumption. GeoJournal 57, 283–294.

Cano-Marquina A, Tarin JJ & Cano A (2013) The impact of coffee on health. Maturitas 75, 7–21. PubMed

Jiang X, Zhang D & Jiang W (2014) Coffee and caffeine intake and incidence of type 2 diabetes mellitus: a meta-analysis of prospective studies. Eur J Nutr 53, 25–38. PubMed

Steffen M, Kuhle C, Hensrud D et al.. (2012) The effect of coffee consumption on blood pressure and the development of hypertension: a systematic review and meta-analysis. J Hypertens 30, 2245–2254. PubMed

Ding M, Bhupathiraju SN, Satija A et al.. (2014) Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose–response meta-analysis of prospective cohort studies. Circulation 129, 643–659. PubMed PMC

Bohn SK, Blomhoff R & Paur I (2014) Coffee and cancer risk, epidemiological evidence, and molecular mechanisms. Mol Nutr Food Res 58, 915–930. PubMed

Corti R, Binggeli C, Sudano I et al.. (2002) Coffee acutely increases sympathetic nerve activity and blood pressure independently of caffeine content: role of habitual versus nonhabitual drinking. Circulation 106, 2935–2940. PubMed

Godos J, Pluchinotta FR, Marventano S et al.. (2014) Coffee components and cardiovascular risk: beneficial and detrimental effects. Int J Food Sci Nutr 65, 925–936. PubMed

Ludwig IA, Clifford MN, Lean ME et al.. (2014) Coffee: biochemistry and potential impact on health. Food Funct 5, 1695–1717. PubMed

Ahmed HN, Levitan EB, Wolk A et al.. (2009) Coffee consumption and risk of heart failure in men: an analysis from the Cohort of Swedish Men. Am Heart J 158, 667–672. PubMed PMC

Happonen P, Laara E, Hiltunen L et al.. (2008) Coffee consumption and mortality in a 14-year follow-up of an elderly northern Finnish population. Br J Nutr 99, 1354–1361. PubMed

Laaksonen M, Talala K, Martelin T et al.. (2008) Health behaviours as explanations for educational level differences in cardiovascular and all-cause mortality: a follow-up of 60000 men and women over 23 years. Eur J Public Health 18, 38–43. PubMed

Leurs LJ, Schouten LJ, Goldbohm RA et al.. (2010) Total fluid and specific beverage intake and mortality due to IHD and stroke in the Netherlands Cohort Study. Br J Nutr 104, 1212–1221. PubMed

Grosso G, Stepaniak U, Micek A et al.. (2014) Association of daily coffee and tea consumption and metabolic syndrome: results from the Polish arm of the HAPIEE study. Eur J Nutr 54, 1129–1137. PubMed PMC

Grosso G, Stepaniak U, Polak M et al.. (2015) Coffee consumption and risk of hypertension in the Polish arm of the HAPIEE cohort study. Eur J Clin Nutr 70, 109–115. PubMed PMC

Peasey A, Bobak M, Kubinova R et al.. (2006) Determinants of cardiovascular disease and other non-communicable diseases in Central and Eastern Europe: rationale and design of the HAPIEE study. BMC Public Health 6, 255. PubMed PMC

Willett WC, Sampson L, Stampfer MJ et al.. (1985) Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 122, 51–65. PubMed

Brunner E, Stallone D, Juneja M et al.. (2001) Dietary assessment in Whitehall II: comparison of 7 d diet diary and food-frequency questionnaire and validity against biomarkers. Br J Nutr 86, 405–414. PubMed

Lof M, Sandin S, Yin L et al.. (2015) Prospective study of coffee consumption and all-cause, cancer, and cardiovascular mortality in Swedish women. Eur J Epidemiol 30, 1027–1034. PubMed

Crippa A, Discacciati A, Larsson SC et al.. (2014) Coffee consumption and mortality from all causes, cardiovascular disease, and cancer: a dose–response meta-analysis. Am J Epidemiol 180, 763–775. PubMed

Greenberg JA, Dunbar CC, Schnoll R et al.. (2007) Caffeinated beverage intake and the risk of heart disease mortality in the elderly: a prospective analysis. Am J Clin Nutr 85, 392–398. PubMed

Rosner SA, Akesson A, Stampfer MJ et al.. (2007) Coffee consumption and risk of myocardial infarction among older Swedish women. Am J Epidemiol 165, 288–293. PubMed

Verhoef P, Pasman WJ, Van Vliet T et al.. (2002) Contribution of caffeine to the homocysteine-raising effect of coffee: a randomized controlled trial in humans. Am J Clin Nutr 76, 1244–1248. PubMed

Ammon HP, Bieck PR, Mandalaz D et al.. (1983) Adaptation of blood pressure to continuous heavy coffee drinking in young volunteers. A double-blind crossover study. Br J Clin Pharmacol 15, 701–706. PubMed PMC

Grosso G, Marventano S, Galvano F et al.. (2014) Factors associated with metabolic syndrome in a mediterranean population: role of caffeinated beverages. J Epidemiol 24, 327–333. PubMed PMC

Myers MG (1988) Effects of caffeine on blood pressure. Arch Intern Med 148, 1189–1193. PubMed

Robertson D, Wade D, Workman R et al.. (1981) Tolerance to the humoral and hemodynamic effects of caffeine in man. J Clin Invest 67, 1111–1117. PubMed PMC

Tamakoshi A, Lin Y, Kawado M et al.. (2011) Effect of coffee consumption on all-cause and total cancer mortality: findings from the JACC study. Eur J Epidemiol 26, 285–293. PubMed

Grosso G, Marventano S, Yang J et al.. (2015) A comprehensive meta-analysis on evidence of Mediterranean diet and cardiovascular disease: are individual components equal? Crit Rev Food Sci Nutr (Epublication ahead of print version). PubMed

Grosso G, Stepaniak U, Topor-Madry R et al.. (2014) Estimated dietary intake and major food sources of polyphenols in the Polish arm of the HAPIEE study. Nutrition 30, 1398–1403. PubMed PMC

Perez-Jimenez J, Fezeu L, Touvier M et al.. (2011) Dietary intake of 337 polyphenols in French adults. Am J Clin Nutr 93, 1220–1228. PubMed

Tresserra-Rimbau A, Medina-Remon A, Perez-Jimenez J et al.. (2013) Dietary intake and major food sources of polyphenols in a Spanish population at high cardiovascular risk: the PREDIMED study. Nutr Metab Cardiovasc Dis 23, 953–959. PubMed

Zamora-Ros R, Knaze V, Rothwell JA et al.. (2015) Dietary polyphenol intake in Europe: the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Eur J Nutr 55, 1359–1375. PubMed PMC

Zujko ME, Witkowska AM, Waskiewicz A et al.. (2012) Estimation of dietary intake and patterns of polyphenol consumption in Polish adult population. Adv Med Sci 57, 375–384. PubMed

Pellegrini N, Serafini M, Colombi B et al.. (2003) Total antioxidant capacity of plant foods, beverages and oils consumed in Italy assessed by three different in vitro assays. J Nutr 133, 2812–2819. PubMed

Lopez-Garcia E, van Dam RM, Qi L et al.. (2006) Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women. Am J Clin Nutr 84, 888–893. PubMed

Jin UH, Lee JY, Kang SK et al.. (2005) A phenolic compound, 5-caffeoylquinic acid (chlorogenic acid), is a new type and strong matrix metalloproteinase-9 inhibitor: isolation and identification from methanol extract of Euonymus alatus . Life Sci 77, 2760–2769. PubMed

Cardenas C, Quesada AR & Medina MA (2011) Anti-angiogenic and anti-inflammatory properties of kahweol, a coffee diterpene. PLoS One 6, e23407. PubMed PMC

Wang S, Yoon YC, Sung MJ et al.. (2012) Antiangiogenic properties of cafestol, a coffee diterpene, in human umbilical vein endothelial cells. Biochem Biophys Res Commun 421, 567–571. PubMed

Hartley TR, Lovallo WR & Whitsett TL (2004) Cardiovascular effects of caffeine in men and women. Am J Cardiol 93, 1022–1026. PubMed

Thong FS & Graham TE (2002) Caffeine-induced impairment of glucose tolerance is abolished by β-adrenergic receptor blockade in humans. J Appl Physiol 92, 2347–2352. PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...